| pubmed-article:8040675 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0278627 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0039286 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0065864 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0279025 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:8040675 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:8040675 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:8040675 | pubmed:dateCreated | 1994-8-25 | lld:pubmed |
| pubmed-article:8040675 | pubmed:abstractText | To determine in a prospective randomized trial whether high-dose orally administered medroxy-progesterone acetate (MPA) was superior to tamoxifen in patients with recurrent or metastatic breast cancer who had received no prior endocrine therapy in either the adjuvant or advanced setting. | lld:pubmed |
| pubmed-article:8040675 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8040675 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8040675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8040675 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8040675 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:8040675 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:PowellB LBL | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:BeardenJ... | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:CooperM RMR | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:MussH BHB | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:CruzJ MJM | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:JacksonD... | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:AtkinsJ NJN | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:O'RourkeM AMA | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:DAMEN GNG | lld:pubmed |
| pubmed-article:8040675 | pubmed:author | pubmed-author:PavyM DMD | lld:pubmed |
| pubmed-article:8040675 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8040675 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:8040675 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8040675 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:8040675 | pubmed:pagination | 1630-8 | lld:pubmed |
| pubmed-article:8040675 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:meshHeading | pubmed-meshheading:8040675-... | lld:pubmed |
| pubmed-article:8040675 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8040675 | pubmed:articleTitle | Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. | lld:pubmed |
| pubmed-article:8040675 | pubmed:affiliation | Comprehensive Cancer Center, Wake Forest University, Winston-Salem, NC 27157-1082. | lld:pubmed |
| pubmed-article:8040675 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8040675 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8040675 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8040675 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8040675 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8040675 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8040675 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8040675 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8040675 | lld:pubmed |
